Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MICR 386 > Module 9 > Flashcards

Module 9 Flashcards

Clinical Applications of Immunology

1
Q

hypersensitivity reactions

A

a detrimental effect of the immune system
- a reaction is termed hypersensitive either because it is a heightened or inappropriate response to an antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gell-Coombs classification of immune injury

A

this system categorizes hypersensitivity reactions into 4 types: Type I, II, III, and IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Type I hypersensitivity

A

Type I immediate hypersensitivity reactions can develop into anaphylactic responses
- type I is a specific antibody mediated reaction
- IgE on the surface of mast cells binds an allergen, resulting in mast cell degranulation
- some of the complement reaction byproducts (C3a, C4a, and C5a) can also cause this type of reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

type II hypersensitivity

A

mediated by antibody directed against cell surface antigens
- AKA cytotoxic or costimulatory hypersensitivity
Type II reactions result in complement mediated lysis or cytotoxic action by NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

type III hypersensitivity

A

mediated by Ab-Ag immune complex deposited on the tissue
these immune complexes can activate complement and recruit innate immune cells to cause tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

type IV hypersensitivity reactions

A

involve a complex interaction of T cells and monocytes/macrophages
- called delayed hypersensitivity (DHT) reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

immediate/anaphylactic hypersensitivity

A

a type I reaction is an immediate response to an allergen
- most of these allergens are enzymes or glycoproteins.
- typical allergens include Fel d1 and Fel d4, Fra a1, der p1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

sensitization

A

may occur via many routes including oral ingestion, respiratory inhalation, skin absorption, and IV
- the reaction is a result of IgE-mediated mast cell degranulation and are T cell dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

type I hypersensitivity mechanism

A
  1. APCs present the processed allergen to Th2 cells. activated Th2 cells secrete IL-4 and IL-13, which induce naive B cells to undergo class switching from IgM to IgG2 to IgE secreting B cells
  2. secreted IgE binds to the F c-epsilon receptor on mast cells. the allergen cross-links two IgE antibodies bound to mast cells, resulting in mast cell degranulation
  3. mast cell degranulation results in the release of mediators, including vasoactive amines, which elicit biological effects within minutes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

type I: mast cell activation

A

activated mast cells released pre-formed molecules and synthesize new vasoactive amines, leading to both early and late phase biological effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

early phase biological effects

A

immediate biological effects on mast cell activation are the result of the release of pre-formed molecules, such as:
- histamine, which promotes vascular permeability and smooth muscle contraction
- eosinophil chemotactic factor, which attracts eosinophils
- neutrophil chemotactic factor, which attracts polymorphic nuclear cells such as mast cells, eosinophils, and neutrophils
- proteases, which increase mucus secretion and causes basement membrane damage, especially in lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

late phase biological effects

A

these are the result of synthesis of new vasoactive amines such as:
- platelet activating factor, which promotes aggregation of platelets, further mast cell degranulation, and smooth muscle contraction
- leukotrienes, which promote smooth muscle contraction and increase vascular permeability
- prostaglandins which promote smooth muscle contraction and vasodilation
- Bradykinin: promotes smooth muscle contraction and vascular permeability; involved in many pain pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

effects of type I hypersensitivity

A

mediators released by mast cells effect:
- Blood Vessels: vasodilation and increased permeability result in edema. this loss of fluid in tissues can lead to anaphylactic shock
- Skin: vasodilation and edema can result in urticaria or eczema
- Nose and Eyes: vasodilation and increased permeability result in edema, which can manifest as rhinitis and conjunctivitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clinical examples of Type I hypersensitivity

A

atopy: a predisposition to developing an allergic reaction

asthma: a condition where airways narrow and swell

laryngeal edema: a condition characterized by swelling of the larynx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

atopy

A

an exaggerated IgE-mediated immune response to an environmental allergen - an inherited condition with genetic association to HLA, and can lead to asthma, atopic dermatitis, and allergic rhinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

asthma

A

a respiratory condition characterized by increase in mucus secretion, edema, and contractions of brochiolar smooth muscle
- inflammation and obstructed airways are characteristic of an asthmatic reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

key pathological components of asthma

A

increased recruitment of inflammatory cells
increased recruitment of mast cells, leading to high levels of histamine
- asthma can be atopic (reaction occurs in part of body not in contact with allergen), which is mediated by systemic IgE production, or non-atopic (reaction occurs in part of body in contact with allergen), which is mediated by localized IgE production, and does not occur in response to an allergen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

laryngeal edema

A

a life-threatening swelling of the larynx characterized by inspiratory stridor (high pitched breathing sound)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

allergy diagnosis

A

a common diagnostic test for immediate hypersensitivity reactions are skin prick tests, which measure the presence of IgE antibodies against suspected and common allergens. a positive reaction occurs within 1-20 minutes and will manifest as a small, red swelling
- this is a diagnostic test for a typical allergen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

type II: cytotoxic/co-stimulatory hypersensitivity

A

these reactions involve antibody-mediated destruction of cells presenting allergens on their surface
- in this reaction, antigen-specific antibodies bind to the cell surface antigen and destroy the cell
- type II reactions are implicated in autoimmune diseases where the cells targeted are the host’s own RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

cell death

A

can occur by one of three mechanisms:
1. complement mediated cell lysis
2. phagocytosis
3. antibody-dependent cell mediated cytotoxicity (ADCC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

type II reaction mechanism: ADCC

A

antigen-specific antibody binds to the antigen via the Fab region
- specifically, cytotoxic cells have the CD16 gene, which binds to the Fc region of the antibody
- this cross linking between the target cell and the cytotoxic cell promotes cell killing due to the release of hydrolytic and digestive enzymes from the cytotoxic cells to the surface of the target cell
- the antibody does not directly kill target cells, but mediates cell death by presenting antigen cytotoxic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

type II reaction: phagocytosis

A

antigen specific antibodies bind to the cell surface antigen via the Fab region. phagocytic cells have Fc receptors that bind to the Fc region of the antibody, cross-linking the antigen with phagocyte cells to enhance the process of phagocytosis
- if complement is activated, it promotes C3b on the surface of the target cell that can bind to the C3b receptor on phagocytes for enhanced phagocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

type II reaction: complement mediated lysis of target cell

A

antibody binding to antigen presented on the cell surface forms an Ab-Ag complex that activates the complement system, ultimately ending in cell lysis through a MAC attack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

clinical examples of Type II reactions

A

hemolytic anemia: a condition where the immune system recognizes its own RBCs as foreign

Bullous pemphigus: autoimmune disease resulting in formation of blisters in the space between dermis and epidermis

Transfusion reactions: adverse reactions to allogeneic RBCs following blood transfusion reactions

Rh disease: a hemolytic condition in which the mother and fetal blood are incompatible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

autoimmune hemolytic anemia

A

a group of blood disorders characterized by fatigue, dyspnea, and pallor. this is a result of lysis of RBCs due to antibodies
- lysis of RBCs consequently decreases the number of oxygen carrying blood cells in circulation

immune cells attack both self-RBCs and allogeneic RBCs that come from outside the individual, such as those from a blood transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

hemolytic disease

A

newborn disease which develops when maternal IgG antibody specific to the Rh-D allele crosses the placenta and destroys fetal RBCs by binding to Rh-D and activating complement
- can be fatal to fetus, but treated with intrauterine blood exchange transfusion
hemolytic disease is prevented by the use of anti-Rh antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

type III: immune complex hypersensitivity

A

these reactions are mediated by immune complexes deposited in the tissue
- these complexes can damage various tissues, primarily through complement activation and recruitment of innate immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

type III inflammatory diseases

A

vasculitis
carditis
synovitis
dermatitis
glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

size of type III immune complex

A

depends on the ratio of antigen:antibody present
- this has implications on the immunogenicity of the complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

type III mechanism

A
  1. antigen:antibody complexes deposit in tissue or blood vessel wall
  2. immune complexes activate complement components and attract inflammatory cells
  3. vasoactive amines (histamine) released by basophils will increase the vascularity of the tissue
  4. prolonged complement activation results in tissue damage due to enzymes released by neutrophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

type III diagnostic application

A

the Arthus reaction is the skin test that detects an excess of local antibodies
- the reaction involves in situ formation of immune complexes after intradermal injection with an antigen
- if a patient has previously been exposed to the antigen and has circulation antibody, an Arthus reaction will occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

arthus reaction

A

not an immediate reaction and generally develops over 6-12 hours if antibody levels are elevated in circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

clinical presentation of type III hypersensitivity

A
  • serum sickness: reaction to proteins in antiserum derived from non-human animals
  • Farmer’s lung: hypersensitivity pneumonitis - rheumatoid arthritis: a long term autoimmune disorder involving both Type II and III hypersensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

serum sickness

A

a reaction to proteins from an animal source which arises from the introduction of certain non-protein substances or following vaccine administration
- the immune system reacts to the foreign antiserum proteins by producing specific antibodies and forming immune complexes, which enter the blood vessels and activate complement cascade
- complement reaction results in hypocomplementemia and fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Farmer’s lung

A

induced by exposure to dust and mold spores found in hay
- occurs when inhaled antigens cause Ig-mediated immune complexes to form in the alveoli. complexes cause fluid, protein, and cells to accumulate in the alveolar wall, compromising the blood-gas exchange in the lungs
- after multiple exposures, it takes fewer antigens to elicit a reaction

37
Q

farmer’s lung symptoms

A

results in fever, chills, and chest pain due to the local reaction in the lungs and occurs about 6-8 hours after exposure

38
Q

rheumatoid arthritis

A

an autoimmune disorder that affects the joints
- the body’s immune system attacks the joints, resulting in inflammation and thickening of the joint capsule
- rheumatoid factor is an IgG or IgM antibody that binds to IgG in synovial joints. the immune complexes deposit in the joints causing injury to articular cartilage

39
Q

type IV: delayed hypersensitivity

A

AKA DTH
reaction requires days to develop, occurs over 48-72 hours
this type of reaction is cell mediated and is initiated by sensitized helper T cells
characterized by the recruitment of activated macrophages at the site of the reaction

40
Q

initiation of DTH

A

requires sensitization by an antigen
- these steps involve uptake, processing, and presentation of the antigen by local APCs. initial exposure of an allergen triggers production of a CD4+ Th1 cell response. this sensitization reactions evolves over a 1-2 week period of time

41
Q

effector phase of DTH

A

the effector phase is induced by a secondary exposure to a sensitizing antigen. Th1 cells enter the sire of antigen presentation, recognizing peptide:MHC Class II complexes on APCs, and release inflammatory cytokines
- cytokines stimulate expression of adhesion molecules on the endothelium to increase local blood vessel permeability to allow macrophages and other cells to enter the site

42
Q

DTH aggregation of cells

A

a prolonged inability to clear antigens can result in aggregation of cells
- characteristic skin lesions appear 24 hours after, reaching their peak 48-72 hours after second exposure

43
Q

DTH diagnostic application

A

DTH reaction can be detected using a skin test. a small amount of sensitizing agent is injected under the skin
- if a red, slightly swollen, firm lesion develops within 48-72 hours, the test is positive, indicating that the individual has a population of sensitized Th1 cells against the pre-exposed antigen
- this does NOT indicate an active infection or if the individual has overcome an infection

44
Q

type IV clinical effects

A

DTH: causes local skin swelling, dermatitis

contact hypersensitivity: caused by hapten antigens, causes local epidermal reactions

celiac disease: antigen is giladen, causes atrophy in small bowel

45
Q

contact dermatitis

A

type IV reaction where sensitization can occur if a reactive chemical compound binds to the skin proteins, and the modified proteins are then presented to T cells. these can be induced by: poison ivy, oak, nickel, cosmetics
reactions cause strong cell-mediated responses against skin cells, including blisters and rashes

46
Q

immune mediators of each reactions

A

I: IgE
II: IgG or IgM
III: immune complexes deposited on tissue
IV: T-cells

47
Q

autoimmune disease

A

AI diseases are the result of over-reactivity of the immune system against its own tissues
- the presence of anti-self antibodies or anti-self mediated immunity will not necessarily develop into an autoimmune disease

AI diseases can be organ specific or systemic, and affect 5-7% of the population. some AI diseases have been linked to certain MHC haplotypes as they could fail to delete anti-self T and B cells

48
Q

central tolerance

A

mechanism by which the immune system learns to discriminate self from non-self antigens
- lymphocytes with receptors to self antigens are removed with apoptosis

49
Q

peripheral tolerance

A

mechanism by which the body prevents over-reactivity of the immune system to various environmental factors such as allergens and microbes

50
Q

defects in tolerance

A

can cause AI disease as lymphocytes specific to self antigen or some environmental factors remain in circulation

51
Q

AI disease and the MHC

A

MHC class II presentation of self or foreign peptides to T cells can result in immunological tolerance.
due to the role of MHC in antigen presentation, some HLA genes have been associated with AI diseases
- individuals with these HLA genes have an increased relative risk for these diseases

52
Q

intrinsic factors to AI susceptibility

A

inheritance of AI diseases can be determined clinically by HLA typing
- individuals with these genes are said to be at very high relative risks (RR) for developing the disease

53
Q

HLA associated diseses

A

insulin dependent diabetes: HLA DR3 haplotype makes it 100x more likely to result in insulin dependent diabetes

ankylosing spondylitis: type of arthritis that affects the spine (vertebrae fuse together, causing rigid spine) HLA B27 haplotype expression makes it 90x more likely to develop

54
Q

mechanisms of autoimmune disease

A

anti-self B and T cells in circulation need to be triggered to become activated
there are 3 major mechanisms for triggering these cells:
1. molecular mimicry
2. release of sequestered antigen
3. polyclonal B cell activation

55
Q

molecular mimicry

A

foreign antigens can have epitopes that are similar to those of self-antigens
- as a result, immune response against a foreign antigen may result in cross activation of the anti-self cells, causing damage to self tissues expressing similar epitopes

since the foreign antigen has similar epitopes to the self antigen, the immune response will attack both

56
Q

molecular mimicry in AI diseases

A

streptococcus bacteria display similar epitopes to those expressed in heart muscle
- molecular mimicry results in rheumatic carditis after infection
- characterized by cardiac inflammation and scarring as a result of cross-reactivity of antibodies due to molecular mimicry

57
Q

diseases caused by antigen mimicry

A

MS: bacteria that cause MS include Epstein-Barr virus, human herpesvirus 6

Ankylosing spondylitis: antibodies against Klebsiella can cross react with HLA B27

58
Q

sequestered antigen

A

self antigens in immunologically privileged sites (brain, eye lens, heart muscle) are sequestered from the immune system
- this is because these self antigens were not presented to developing lymphocytes during maturation, and therefore there was no development of tolerance to these antigens

59
Q

trauma and sequestered antigens

A

in the event of infection or trauma, these sequestered antigens can become exposed to the immune system, which may result in the newly exposed antigens being recognized as foreign, initiating an AI disease

60
Q

clinical example of sequestered antigen

A

sympathetic uveitis is inflammation that occurs following accidental insult to the eye
- these cells have never been exposed to the immune system, therefore when they are exposed because of injury, the body produced antibodies against them (anti-self)

61
Q

polyclonal B cell activation

A

EBV and CMV viruses can activate mature B cells to produce antibodies with different specificities
- the production of a wide range of antibody specificities as a result of infection causes a greater chance of cross-reaction to different antigens, including different bacteria and self antigens
- Anti-DNA and anti-RBC antibodies can result in the development of AI

62
Q

clinical example of polyclonal B cell activation

A

EBV virus causes mono, and infection is transferred through saliva and genital secretions to inject epithelial cells of the oropharynx
- persistent EBV infection can shift between an active lytic cycle and a latent state enabling evasion of the immune system and allows for the initiation of AI disease

63
Q

types of AI diseases

A

AI diseases can be organ specific or systemic
- organ specific AI involve an immune response against self-antigens in a single organ (ex: Grave’s disease or diabetes)
- systemic immune response is self-antigens throughout many different tissues (ex: arthritis)

64
Q

organ specific: myasthenia gravis

A

a chronic autoimmune disease that results from antibodies against ACh receptors at the neuromuscular junction, preventing muscle contractions
- under normal conditions, ACh released from the pre-synaptic nerve binds to AChR on the post-synaptic neuron. AChE degrades excess ACh
- with AI, antibodies against AChR prevent ACh binding. this is treated with AChE inhibitors that inhibit AChE degradation of ACh. a higher concentration of ACh increases the likelihood of binding

65
Q

myasthenia gravis treatment

A

patients will experience muscle weakness as a result of antibodies against AChR at the neuromuscular junction. drooping eyelids is characteristic of this disease
- significant improvement is noticeable following AChE inhibitors treatment

66
Q

organ specific: Grave’s disease

A

AI disease that manifests as hyperthyroidism, as a result of antibodies against the TSH receptor
- in Grave’s disease, antibodies against TSH receptor cause chronic activation, producing abnormally high T3 and T4 levels

67
Q

Grave’s disease symptoms

A

bulging eyes
goitre
muscle weakness

68
Q

organ specific AI: Goodpasture’s syndrome

A

AI disorder where antibodies attack the basement membrane of the lung alveoli and glomerulus in kidney
- circulating anti-GBM antibodies bind to epitopes on the basement membrane and activate a complement cascade, leading to bleeding from the lungs and kidney failure

69
Q

systemic: systemic lupus erythematosus

A

the body makes anti-nuclear and anti-cytoplasmic antibodies
- immune complexes are deposited in different tissues, ultimately triggering inflammation that results in conditions such as arthritis, carditis, and dermatitis

70
Q

systemic: rheumatoid arthritis

A

AI disease that primarily affects the joints. mediated by T cells and/or antibodies

71
Q

rheumatoid arthritis: T cells

A

Th1 cells engage with a specific antigen in the joints, and they release cytokines that initiate local inflammation
- leukocyte recruitment causes damage to the cartilage in the joint leading to its destruction

72
Q

arthritis: antibodies

A

RA involves IgM anti-IgG autoantibody (RF factor) which deposit in joints and blood vessels and are associated with destructive inflammation

73
Q

primary immunodeficiency

A

caused by hereditary or genetic defects that result in the absence or improper functioning of parts of the body’s immune system
- AI diseases of this type share a common factor of causing a defect in one of the body’s immune system functions, either by affecting one component or multiple components of the immune system

74
Q

primary immunodeficiency classifications

A

classified based on which part of the immune system is affected
- humoral immunity (B-cells)
- cellular immunity (T-cells)
- humoral and cellular immunity (B and T cells)

the affected component of the immune system can be missing, reduced in number, or abnormal, and malfunctioning, immunodeficiencies involving problems with B cells account for more than half the primary immunodeficiency disorders

75
Q

digeorge syndrome: T cell deficiency

A

primary immunodeficiency that is the result of a deletion of a segment of chromosome 22
- causes developmental thymic aplasia, in which the thymus fails to develop, where T cells are supposed to mature.
- this causes the absence of of cell mediated immunity due to lack of differentiated or immune T cells
- patients have an increased susceptibility to fungal and viral infections

76
Q

Bruton’s agammaglobulinema

A

inherited immunodeficiency disease caused by mutations in the gene coding for BTK, which is responsible for mediating B cell development
- individuals do not generate mature B cells, resulting in a lack of Ig in the bloodstream. individuals are prone to serious and fatal bacterial infections

77
Q

treating Bruton’s

A

XLA is typically treated by IV infusion of antibodies
- does not cure XLA, but reduces severity of infections due to passive immunity

78
Q

SCID

A

a group of defects from one of many genes that results in a heterogenous disorder
- defective genes play a role in the proper development of B and T cells, and SCID causes a defective antibody response either directly through mature B cell malfunctioning, or indirectly through ineffective T cell dependent B cell activation
- SCID causes affected individuals to be highly susceptible to life threatening infections by viruses, bacteria, and fungi
- infected individuals must live in a sterile environment

79
Q

mechanisms of SCID development

A

most cases of SCID are X lined, due to mutations in the gene that codes for the common gamma chain on the X chromosome
- mutations prevent the development of a fully functional immune system due to low T cell and NK cell count, and non-functional B cells
- receptors for certain cytokines are not functional and cannot exert their effects

80
Q

acquired immunodeficiency

A

not genetic, but caused by external factors
four main causes: malnutrition, medication, aging, and disease

81
Q

malnutrition

A

deficiency in one or more nutrients can result in the improper functioning of the immune system
- mainly caused by protein calorie deficiency, where the T cell population decreases in proportion to protein levels

82
Q

medication immunodeficiency

A

cytotoxic agents such as chemotherapy and radiation therapy target rapidly dividing cells in the body, but this effect can suppress the immune system

83
Q

aging: immunodeficiency

A

the thymus shrinks as you age, and the thymus produces fewer T cells that can respond to antigens
- micronutrient malnutrition is a particular concern for aging population as it impairs the immune system
- calcium and zinc are common deficiencies in the elderly

84
Q

disease: immunodeficiency

A

prolonged or chronic disorders can result in secondary immunodeficiency due to stress placed on immune system

85
Q

HIV

A

most common secondary immunodeficiency, transmitted through bodily fluids
- HIV interacts with CD4 and CCR5 receptors
- viral reverse transcriptase copies RNA genome of HIV and integrates it into host genome

86
Q

effects of HIV

A

direct viral effect on infected cells as the budding process of the virus destroys the membrane of the infected cells
- additionally, cells die from apoptosis induced by over-expression of antigenic ligands
- accelerated apoptosis accounts for the low CD4+ T-cell counts

87
Q

consequences of HIV

A

loss of CD4+ helper T cells contributes to the abnormal production of IL-1 and TNF-a
- collectively, this leads to decreased proliferation in response to antigens, decreasing DHT and cell mediated immunity against infections

88
Q

immunological abnormalities of HIV

A

abnormal macrophage function (IL-1)
decreased NK cell activity
decreased CD8+ cytotoxic T cells
increased non-specific Ig
increased auto-antibodies

89
Q

idiopathic immunodeficiencies

A

diseases that have an unknown cause
- most commonly B cell immunodeficiencies
- includes CVID (defects in the antibody variable region) and selective IgA deficiency (foreign IgA elicits an immune response)

MICR 386 (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions